Antiplatelet therapy preceding coronary artery surgery: implications for bleeding, transfusion requirements and outcome
about
Novel platelet ADP P2Y12 inhibitors in the treatment of acute coronary syndrome.Modern antiplatelet agents in coronary artery disease.Understanding the delicate balance between bleeding and thrombosis: can we use it to our advantage?Impact of preoperative use of P2Y12 receptor inhibitors on clinical outcomes in cardiac and non-cardiac surgery: A systematic review and meta-analysis.Preserved functional and biochemical characteristics of platelet components prepared with amotosalen and ultraviolet A for pathogen inactivation.
P2860
Antiplatelet therapy preceding coronary artery surgery: implications for bleeding, transfusion requirements and outcome
description
2007 nî lūn-bûn
@nan
2007 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2007 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
name
Antiplatelet therapy preceding ...... usion requirements and outcome
@ast
Antiplatelet therapy preceding ...... usion requirements and outcome
@en
Antiplatelet therapy preceding ...... usion requirements and outcome
@nl
type
label
Antiplatelet therapy preceding ...... usion requirements and outcome
@ast
Antiplatelet therapy preceding ...... usion requirements and outcome
@en
Antiplatelet therapy preceding ...... usion requirements and outcome
@nl
prefLabel
Antiplatelet therapy preceding ...... usion requirements and outcome
@ast
Antiplatelet therapy preceding ...... usion requirements and outcome
@en
Antiplatelet therapy preceding ...... usion requirements and outcome
@nl
P2093
P1476
Antiplatelet therapy preceding ...... usion requirements and outcome
@en
P2093
P356
10.1017/S0265021506002262
P407
P577
2007-04-01T00:00:00Z